Search results
Results From The WOW.Com Content Network
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland.
For premium support please call: 800-290-4726 more ways to reach us
Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets ...
Lonza's Biologics unit produces monoclonal antibodies and drug conjugates, and comprises approximately 45% of its annual sale Swiss pharma firm Lonza's profit falls less than feared, shares rise ...
But for buy-and-hold investors, given a high, consistent dividend and an astounding cumulative compound return of more than 2.6 million percent over 98 years, it’s hard to argue with the stock ...
Language links are at the top of the page across from the title.
Graphite mining in Sri Lanka has occurred since the Dutch occupation of the country. It is the only country in the world to produce the purest form of graphite, vein graphite (also known as lump graphite), in commercial quantities, currently accounts for less than 1% of the world graphite production.
Adobe Firefly, Tyler Le/BI. Stifel warns of a sharp stock market correction by year-end, with the S&P 500 potentially dropping 12%. Chief equity strategist Barry Bannister said high valuations and ...